<DOC>
	<DOC>NCT00333073</DOC>
	<brief_summary>To assess effectiveness of Bulkamid® injection in females suffering from stress or mixed (stress and urge) urinary incontinence after 12 months follow up period</brief_summary>
	<brief_title>Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<criteria>Informed consent Symptomatic stress or mixed urinary incontinence for at least 12 months Having at least 1 incontinence episode per day over three days Regular or intermittent users of an urethral catheter Pregnant women Suffer from severe allergies or anaphylaxis Suffer from autoimmune diseases or any unstable or sever cardiovascular disease History of any cancer within the last 5 years Previous surgery for the treatment of urinary incontinence, including bulking</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>urinary incontinence</keyword>
	<keyword>Bulkamid</keyword>
</DOC>